Use of Favipiravir to Treat Lassa Virus Infection in Macaques

Bibliographic Details
Title: Use of Favipiravir to Treat Lassa Virus Infection in Macaques
Authors: Kyle Rosenke, Heinz Feldmann, Jonna B. Westover, Patrick William Hanley, Cynthia Martellaro, Friederike Feldmann, Greg Saturday, Jamie Lovaglio, Dana P. Scott, Yousuke Furuta, Takashi Komeno, Brian B. Gowen, David Safronetz
Source: Emerging Infectious Diseases, Vol 24, Iss 9, Pp 1696-1699 (2018)
Publisher Information: Centers for Disease Control and Prevention, 2018.
Publication Year: 2018
Collection: LCC:Medicine
LCC:Infectious and parasitic diseases
Subject Terms: Lassa virus, antiviral, favipiravir, treatment, viruses, macaques, Medicine, Infectious and parasitic diseases, RC109-216
More Details: Lassa virus, the cause of Lassa fever in humans, is endemic to West Africa. Treatment of Lassa fever is primarily supportive, although ribavirin has shown limited efficacy if administered early during infection. We tested favipiravir in Lassa virus–viremic macaques and found that 300 mg/kg daily for 2 weeks successfully treated infection.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1080-6040
1080-6059
Relation: https://wwwnc.cdc.gov/eid/article/24/9/18-0233_article; https://doaj.org/toc/1080-6040; https://doaj.org/toc/1080-6059
DOI: 10.3201/eid2409.180233
Access URL: https://doaj.org/article/3aecf98e94ba4838974e7b84ddf68363
Accession Number: edsdoj.3aecf98e94ba4838974e7b84ddf68363
Database: Directory of Open Access Journals
More Details
ISSN:10806040
10806059
DOI:10.3201/eid2409.180233
Published in:Emerging Infectious Diseases
Language:English